Original language | English (US) |
---|---|
Pages (from-to) | 2975-2979 |
Number of pages | 5 |
Journal | Leukemia and Lymphoma |
DOIs | |
State | Published - 2020 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Leukemia and Lymphoma, 2020, p. 2975-2979.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Predictors of short-term survival in Waldenström Macroglobulinemia
AU - Ruan, Gordon
AU - Zanwar, Saurabh
AU - Abeykoon, Jithma P.
AU - Ansell, Stephen M.
AU - Gertz, Morie
AU - Go, Ronald S.
AU - Muchtar, Eli
AU - Gonsalves, Wilson I.
AU - Paludo, Jonas
AU - Thanarajasingam, Gita
AU - Inwards, David J.
AU - Thompson, Carrie A.
AU - Habermann, Thomas M.
AU - Lin, Yi
AU - Nowakowski, Grzegorz S.
AU - Bisneto, Jose C.Villasboas
AU - Dispenzieri, Angela
AU - Lacy, Martha Q.
AU - Buadi, Francis K.
AU - Dingli, David
AU - Kourelis, Taxiarchis
AU - Warsame, Rahma
AU - Rajkumar, S. Vincent
AU - Kumar, Shaji
AU - Kapoor, Prashant
N1 - Funding Information: Dr. Kumar reports grants and other support from Abbvie, Celgene, Janssen, Takeda, Adaptive, KITE, Medimmune/Astra Zeneca; grants from Merck, Novartis, Roche, Sanofi; other support from Oncopeptides, outside the submitted work Funding Information: Dr. Dispenzieri reports other support from Alnylam, Intellia, Janssen; grants from Takeda, Pfizer, Prothena, Celgene, Alnylam, Janssen, outside the submitted work. Funding Information: Dr. Dingli reports personal fees from Alexion, Janssen, Milleneum/Takeda, GSK, Rigel Therapeutics, Apellis; grants from Karyopharm, outside the submitted work.
PY - 2020
Y1 - 2020
UR - http://www.scopus.com/inward/record.url?scp=85088116266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088116266&partnerID=8YFLogxK
U2 - 10.1080/10428194.2020.1789625
DO - 10.1080/10428194.2020.1789625
M3 - Letter
C2 - 32662697
AN - SCOPUS:85088116266
SN - 1042-8194
SP - 2975
EP - 2979
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
ER -